Ligand Pharmaceuticals
LGND
#3212
Rank
A$6.75 B
Marketcap
A$336.91
Share price
0.38%
Change (1 day)
100.04%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$0.24 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.26 Billion. , an increase over its 2024 earnings that were of A$7.86 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 A$0.23 B2848.57%
2024 A$7.86 M-91.37%
2023 A$91.08 M-7.59%
2022 A$98.56 M4%
2021 A$94.77 M296.42%
2020 A$23.9 M-97.97%
2019 A$1.17 B275.62%
2018 A$0.31 B237.48%
2017 A$92.99 M49.05%
2016 A$62.39 M55.41%
2015 A$40.14 M36.87%
2014 A$29.33 M29.59%
2013 A$22.63 M1309.35%
2012 A$1.6 M-43.97%
2011 A$2.86 M-113.19%
2010 -A$21.74 Million59.86%
2009 -A$13.6 Million-61.33%
2008 -A$35.16 Million-58.75%
2007 -A$85.22 Million20.52%
2006 -A$70.72 Million81.27%
2005 -A$39.01 Million
2003 -A$27.16 Million-20.6%
2002 -A$34.21 Million4.38%
2001 -A$32.77 Million-48.83%
2000 -A$64.04 Million-19.74%
1999 -A$79.79 Million-19.06%
1998 -A$98.57 Million126.71%
1997 -A$43.48 Million-5.83%
1996 -A$46.17 Million136.23%
1995 -A$19.55 Million-33.97%
1994 -A$29.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.79 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.99 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.07 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.86 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.72 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.62 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.59 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.17 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$87.64 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA